Extracellular protons (H+)

Extracellular protons (H+) are fundamental ions that determine the acidity of the local environment, playing a pivotal role in both normal physiology and various disease states. In healthy tissues, extracellular pH is tightly regulated around 7.4, but in pathological conditions like solid tumors, inflammation, and ischemia, proton accumulation leads to significant local acidosis (Source: Nature Reviews Cancer, 2013). This acidic microenvironment serves as a potent signaling stimulus, activating specialized proton-sensing receptors such as Acid-Sensing Ion Channels (ASICs) and certain G protein-coupled receptors (e.g., GPR4, TDAG8), which mediate pain perception and inflammatory responses (Source: Journal of Clinical Investigation, 2013). In oncology, extracellular acidity is a hallmark of the tumor microenvironment, driven by increased glycolytic metabolism and poor vascularization; it promotes extracellular matrix degradation, facilitates metastasis, and impairs the activity of infiltrating immune cells (Source: Cancer Research, 2019). Therapeutic interventions aim to modulate this environment through the use of chemical buffers like sodium bicarbonate, inhibitors of proton-exporting enzymes such as Carbonic Anhydrase IX (CAIX), or pH-responsive nanoparticles designed for targeted drug release (Source: Trends in Pharmacological Sciences, 2019).

Other names

Extracellular acidityLow extracellular pHAcidic microenvironmentTumor acidityHydronium ionspHe

Therapeutic modulation occurs through direct chemical neutralization (buffering), inhibition of proton-extruding transporters and enzymes (e.g., CAIX, V-ATPase, NHE1) to prevent extracellular acidification, or pharmacological blockade of proton-sensing receptors (e.g., ASICs) to prevent downstream signaling.